Protein Biochips Market Share

North American Market Forecast

The protein biochips market in North America is projected to be the largest with a share of about 38% by the end of 2036. The growth of the market can be attributed majorly to the growing awareness among healthcare professionals regarding the various advantages associated with protein biochips. This includes better accuracy, sensitivity, and specificity of the results, as well as their ability to provide quick and reliable results. Moreover, the lack of access to proper healthcare and nutrition, as well as the prevalence of unhealthy lifestyle choices, has caused a dramatic increase in the number of people suffering from chronic diseases such as diabetes, hypertension, and heart disease in the region. As reported by the Centers for Disease Control and Prevention CDC, in 2022, 6 out of 10 adults in the United States had a chronic illness, while 4 out of 10 adults had two or more chronic illnesses.

Asia Pacific Market Statistics

The Asia Pacific protein biochips market is estimated to be the second largest, registering a share of about 27% by the end of 2036. The growth of the market can be attributed majorly to the increasing health consciousness among people and rising awareness of the benefits of protein-based functional food and beverages are some of the major factors driving the growth of the market. Moreover, the rapid growth in life sciences research activities in India, and China supported by biotechnology and pharmaceutical research, and low infrastructure costs are significant factors driving the development of protein biochip market in the APAC region.